Dr. Stein-Merlob is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Medical Plaza
Suite 630w
Los Angeles, CA 90095Phone+1 310-825-9011Fax+1 310-825-9012
Education & Training
- Harvard Medical SchoolClass of 2015
Certifications & Licensure
- CA State Medical License 2016 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 30 citationsImmunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies.Ashley F Stein-Merlob, Michael Rothberg, Patrick Holman, Eric H. Yang
Current Cardiology Reports. 2021-01-22 - 36 citationsCardiotoxicities of novel cancer immunotherapies.Ashley F Stein-Merlob, Michael Rothberg, Antoni Ribas, Eric H. Yang
Heart. 2021-03-15 - 18 citationsBlood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study.Ashley F. Stein-Merlob, Chase W. Kessinger, S. Sibel Erdem, Henry Zelada, Scott A. Hilderbrand
Theranostics. 2015-09-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: